RESSAISSI, AsmaPacheco, RitaSerralheiro, Maria Luisa2021-10-142021-10-142021-10-15RESSAISSI, Asma; PACHECO, Rita; SERRALHEIRO, Maria Luísa M. – Molecular-level changes induced by hydroxycinnamic acid derivatives in HepG2 cell line: comparison with pravastatin. Life Sciences. ISSN 0024-3205. Vol. 283 (2021), pp. 1-110024-3205http://hdl.handle.net/10400.21/13892Hydroxycinnamic acid derivatives are an important class of polyphenols found in fruits, vegetables, and medicinal plants and widely consumed in human diet. In the present work, alterations of HepG2 cells biochemical profile under the effect of four hydroxycinnamic acid derivatives (caffeic acid, m-coumaric acid, chlorogenic acid and rosmarinic acid) relatively to the effect of pravastatin, a drug often prescribed to inhibit HMG-CoA reductase enzyme, the regulator enzyme in the cholesterol biosynthesis pathway, were reported. The application of FTIR spectroscopy in combination with multivariate analysis by PCA showed a similarity between pravastatin and the four hydroxycinnamic acid derivatives in metabolite profile modification expressed by various changes in proteins region, the phosphate region which mainly corresponds to nucleic acids as well as in lipids regions. FTIR structural analysis in the amide I region, using resolution enhancement methods, such as second derivative and amide I deconvolution method, revealed significant decrease in alpha-helix/random coil and intermolecular beta-sheet decreased while intramolecular beta-sheet in treated cells showed an increase. It was also noticed that the intracellular cholesterol as well as esterified ingredients such as cholesterol esters in the cell membrane decreased. Moreover, principal component analysis (PCA) of the spectral data showed that the compounds and pravastatin were well separated from untreated cells showing a different mode of action on HepG2 treated cells for each compound.engHydroxycinnamic acid derivativesPravastatinHepG2FTIR spectroscopyPCAMolecular-level changes induced by hydroxycinnamic acid derivatives in HepG2 cell line: comparison with pravastatinjournal article10.1016/j.lfs.2021.1198461879-0631